162 related articles for article (PubMed ID: 22276832)
1. Briakinumab versus methotrexate for psoriasis.
Malgarini RB; Pimpinella G
N Engl J Med; 2012 Jan; 366(4):379; author reply 380. PubMed ID: 22276832
[No Abstract] [Full Text] [Related]
2. Briakinumab versus Methotrexate for Psoriasis.
Wu JJ
N Engl J Med; 2012 Jan; 366(4):379-80; author reply 380. PubMed ID: 22276833
[No Abstract] [Full Text] [Related]
3. A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis.
Reich K; Langley RG; Papp KA; Ortonne JP; Unnebrink K; Kaul M; Valdes JM
N Engl J Med; 2011 Oct; 365(17):1586-96. PubMed ID: 22029980
[TBL] [Abstract][Full Text] [Related]
4. Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate.
Warren RB; Brown BC; Carmichael AJ; Griffiths CE
Clin Exp Dermatol; 2009 Apr; 34(3):415-6. PubMed ID: 19120390
[No Abstract] [Full Text] [Related]
5. Infliximab combined with methotrexate as long-term treatment for erythrodermic psoriasis.
Heikkilä H; Ranki A; Cajanus S; Karvonen SL
Arch Dermatol; 2005 Dec; 141(12):1607-10. PubMed ID: 16365275
[No Abstract] [Full Text] [Related]
6. [Treatment of severe psoriasis with anti-TNF-alpha-antibody and methotrexate].
Dalaker M; Bonesrønning JH
Tidsskr Nor Laegeforen; 2003 Apr; 123(8):1070-1. PubMed ID: 12760225
[No Abstract] [Full Text] [Related]
7. Infliximab- and methotrexate-resistant rebound of psoriasis after discontinuation of efalizumab (Raptiva).
Thielen AM; Barde C; Saurat JH
Br J Dermatol; 2006 Oct; 155(4):846-7. PubMed ID: 16965444
[No Abstract] [Full Text] [Related]
8. Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis.
Nijsten T; Spuls PI
Br J Dermatol; 2008 Jul; 159(1):257-8. PubMed ID: 18489593
[No Abstract] [Full Text] [Related]
9. Childhood generalized pustular psoriasis: longtime remission with combined infliximab and methotrexate treatment.
Skrabl-Baumgartner A; Weger W; Salmhofer W; Jahnel J
Pediatr Dermatol; 2015; 32(1):e13-4. PubMed ID: 25644044
[TBL] [Abstract][Full Text] [Related]
10. Infliximab for the treatment of severe pustular psoriasis.
Elewski BE
J Am Acad Dermatol; 2002 Nov; 47(5):796-7. PubMed ID: 12399781
[No Abstract] [Full Text] [Related]
11. Efficacy of ustekinumab in palmoplantar psoriasis.
Bulai Livideanu C; Lahfa M; Mazereeuw-Hautier J; Paul C
Dermatology; 2010; 221(4):321-3. PubMed ID: 20980724
[No Abstract] [Full Text] [Related]
12. Ustekinumab treats psoriasis refractory to seven conventional and biologic therapies.
Rallis E; Verros CD
Dermatol Online J; 2011 Apr; 17(4):14. PubMed ID: 21549089
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis.
Gottlieb AB; Leonardi C; Kerdel F; Mehlis S; Olds M; Williams DA
Br J Dermatol; 2011 Sep; 165(3):652-60. PubMed ID: 21574983
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis.
Strober BE; Crowley JJ; Yamauchi PS; Olds M; Williams DA
Br J Dermatol; 2011 Sep; 165(3):661-8. PubMed ID: 21574984
[TBL] [Abstract][Full Text] [Related]
15. Effective management of psoriasis symptom worsening during efalizumab therapy without discontinuing treatment: a case study.
Gisondi P; Giglio MD; Girolomoni G
J Dermatolog Treat; 2006; 17(3):172-5. PubMed ID: 16854760
[TBL] [Abstract][Full Text] [Related]
16. Long-term management of generalized pustular psoriasis with infliximab: case series.
Routhouska SB; Sheth PB; Korman NJ
J Cutan Med Surg; 2008; 12(4):184-8. PubMed ID: 18627699
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate in severe childhood psoriasis.
Dogra S; Handa S; Kanwar AJ
Pediatr Dermatol; 2004; 21(3):283-4. PubMed ID: 15165222
[No Abstract] [Full Text] [Related]
18. Chronic plaque psoriasis.
Naldi L; Rzany B
Clin Evid; 2006 Jun; (15):2249-83. PubMed ID: 16973087
[No Abstract] [Full Text] [Related]
19. Response to the letter to editor re: "Methotrexate and psoriasis: consensus conference".
Menter A
J Am Acad Dermatol; 2012 Apr; 66(4):689; author reply 689-90. PubMed ID: 22421115
[No Abstract] [Full Text] [Related]
20. [Body-weight changes in psoriatic patients on systemic treatment].
Forien M; Mahé E; Sin C; Marchal A; Sigal ML
Ann Dermatol Venereol; 2012 Oct; 139(10):649-51. PubMed ID: 23122380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
